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Abstract
Drosophila is a powerful genetic model system to study cancer. In patients, a small number of mutations
accumulate in cells that change their growth characteristics and eventually lead to the formation of tumors.
These tumors are clonal in origin, meaning the cancer arose from the proliferation of a single rogue cell.
We have developed similar "clonal" cancer models in the Drosophila brain to study how tumor cells
interact among each other and with their neighbors. To study such interactions, we need to tag the tumor
cells and their neighboring cells. Such differentially marked clone-pairs or ‘twin-spots’ are ideal for genetic
and biochemical analysis. In this proposal, our goal is to develop tools to manipulate either the tumor or the
normal neighboring cells or both, and test the effect on tumor growth and progression. These studies will
allow deeper analysis of early changes in the tumor that are precursors for the aggressive and invasive
characteristics found later. We will use glioma – a lethal brain tumor – as the cancer type of interest, and
will use the variety of genetic tools available in flies to generate the twin-spots using different fluorescent
tags.
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Abstract
Glioma are glia-derived brain tumors that grow aggressively and ultimately result in
patient death as there is no cure to date despite surgical and therapeutic interventions
(radio- and chemotherapy). Many studies have shown that human diseases can be
functionally conserved in Drosophila, thus, we have come up with experiments to
manipulate gene expression in two cell populations that will help us understand more
about how cells surrounding a tumor behave. We will use a Drosophila glioma model to
study these cell-cell interactions. Establishing our experiment, we expect one population
to grow into a glioma tumor and the other population to be comprised of cells that
express stress-inducing genes. This will allow us to study the effects of wound-healing
related genes to study the effects on the neighboring glioma tumors. We hypothesize
that interclonal interactions promote tumor growth. We will combine the GAL4-UAS
system with the Lex-AOP system to develop our twin-spot two-clone models. Preliminary
results from Cut-lexA, Chimno-lexA, and Ey-lexA crossed with AOP-RFP, and crossing
Cut-lexA with Reaper (which induces cell death mediated stress) shows promising
results. To further test our hypothesis, we have devised two aims. The first aim is to
generate a positively marked two-clone interclonal model by generating tumor growth in
Drosophila Brain and understand the behavior of the glial cell surrounding the dead
tumor cell. The second aim is to test interclonal tumor interactions using apoptotic and
cytotoxic stress by dissecting larvae to determine the effect on tumor size and the
intercolonal tumor interactions. By targeting glial cells that grow the closest in proximity
to the tumor growth, it will allow us to understand cell behavior of the surrounding cell
signals when the tumor cells die.
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Chapter 1
Background & Literature Review
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1.1 Introductory Description of Glioma
Glioma account for approximately 70% of human malignant primary brain tumors, and
glioblastoma multiforme (GBM) is the most commonly diagnosed as adult glioma
(World Health Organization grade IV). Current standard of care includes surgery,
radiation, and chemotherapy, yet despite these treatments, the median survival time for
GBM is only approximately 4.5 months (Yamada and Nakano 2012) with a 72% chance
of recurrence in many patients (Milano et al, 2010).
Because human disease linked genes are functionally conserved in Drosophila (Chien et
al., 2002; Hirth, 2010; Pandey and Nichols, 2011; Read, 2011), it makes Drosophila
melanogaster a powerful model to study cancer and other human diseases. One
advantage of using Drosophila genetics is that it can be used to identify new genes and
signaling pathways. Another advantage of using Drosophila is the cost – it is less
expensive and requires less complicated cell manipulation compared to mouse model
glioma. In addition, findings from Drosophila research e.g., drugs identified in
Drosophila genetic screens have been proven effective in clinical trials in mammalian
models (Dar et al., 2012; Das and Cagan, 2010; Read et al., 2005).
The genetic tools available in Drosophila melanogaster enable us to mimic tumor growth
that happens in humans into a fruit fly model. This genetic toolkit allows manipulation of
gene expression using genetic mosaics to create somatic clones (Bier 2005; St Johnston,
2009, Lee and Luo, 2001). Somatic clones are groups of cells that are genetically
different from the surrounding normal cells, and usually show behaviors that are different
from normal cells. For example, somatic clones can show cancer like effects by dividing
rapidly, forming benign masses, and eventually showing changes akin to metastasis. The
ability to generate and study the growth and progression of such tumor-forming somatic
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mosaic clones one of the distinct advantages of the Drosophila model. These somatic
mosaic clones can be identifies by cellular biomarkers (e.g., Green fluorescent protein,
GFP), which allows tracking and analysis of tumor cells, and their surrounding normal
cells.
Somatic clones can be induced in many different Drosophila tissues to mimic different
disease conditions, for example, the epithelial imaginal discs, the brain, the ovaries/testes
of developing flies, and the intestinal cells of larvae or adults. Thus, many different
disease models can be studies using the mosaic model in flies. In all cells, initially
development happens through a strict growth control process where a pool of
uncommitted cells is generated. As development proceeds, these cells become specialized
through a process called differentiation into key cell types like neurons, epithelial cells,
etc. In addition, stem cells participate in controlling growth and producing cells with
specialized functions.
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1.2 Glioma Development in D. melanogaster
Drosophila brains are bilaterally symmetrical structures with a ventral nerve cord and
two dorsal lobes (Spindler and Hartenstein, 2010) that contain neurons and glia (Apitz
and Salecker, 2014). Therefore, we can use Drosophila glioma model to study the
intercellular interaction between the surviving tumor cells as well as the dying cell to
examine the molecular signals that promote glioma. Currently we induce glioma by
activating two genes, PI3K and Ras, in Drosophila glial cells. These are fly counterparts
of human genes commonly activated in glioma patients. Because there are ample genetic
tools to study Drosophila, it provides an ideal model to study cell-to-cell signaling events
and also provides the ability to dissect multi-gene interactions, identify new gene
functions, and cell-type specific manipulation of gene expression in vivo (Kango-Singh,
2014).
Both in flies and humans, a pool of uncommitted cells generates stem cells in the brain
that are referred to as Neuroblasts. These cells self-renew and produce a group of
differentiated cells by undergoing two to three rounds of cell division to form Neurons
and Glia, two major cell types in the brain. In flies, two types of neuroblasts are
described. Type I neuroblasts divide to produce a Ganglion Mother Cell, which further
divides to form 2 cells – 2 Neurons or 2 Glia or a neuron and a glia each – to form a small
cluster of cells (Figure 1.1). Type II neuroblast cells are more clustered because they
divide to form Interneuron cells which through additional rounds of cell division give rise
to a larger cluster of cells. Both these neuoblast types and their descendants are found in
the human brain as well. Hence, studying defects in growth regulation in flies can provide
insights on human diseases like glioma.
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Figure 1.1 Displays how the two different types of neuroblasts differentiate in
Drosophila. Imagine obtained from:
https://www.google.com/search?biw=1280&bih=728&tbm=isch&sa=1&ei=bL24XI3LEYiKtQWtuaCQDw&q=anatomy+of+3rd+instar+larvae+brain+lo
be&oq=anatomy+of+3rd+instar+larvae+brain+lobe&gs_l=img.3...10836.12388..12534...0.0..0.166.1137.7j4......1....1..gws-wizimg.wY5P42FUNzk#imgrc=DGYp0JHlmwEuUM
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1.3 GAL4-UAS and LexA-lexAOP System
The Gal4 and UAS (upstream activating sequence) system is a potent tool for targeting
gene expression. In Drosophila, these components are carried in separate parental lines
(Busson, 2007). When combined it into one system via crossing two parental lines
together, offspring bear both systems that can be used to activate the sequence of the gene
of interest. In such a case, the Gal4 transcription factor that activates the transcription of
its target genes by binding to the UAS cis-regulatory site; which controls the sequence for
the targeted gene’s sequences (Busson, 2007). This system has been well established in
our lab to produce tumor growth with RNAi and RasV12.
Similar to the GAL4-UAS system, the LexA-LexAOP works the same way. Both are in
individual parental genes. But once crossed, the offspring will carry the LexA-LexAOP
line that enables LexA to act as a driver and bind to LexAOP to activate the transcription
of the targeting gene (del Valle Rodriguez, Alberto et al, 2011). In this experiment, we
used LexA-LexAOP to express Reaper expression in fruit flies.
Creating a binary system with both Gal4-UAS and LexA-LexAOP into one fly will allow
researchers to simultaneously perform two manipulations of gene expression in vivo (del
Valle Rodriguez, Alberto et al, 2011). Researchers can “check whether two reporters are
expressed in the same or different cells” by using “GAL4 to report the expression of one
gene by driving Green Fluorescent Protein (GFP) expression and LexA to report
expression of another gene by driving RFP expression” (del Valle Rodriguez, Alberto et
al, 2011). This system has been done in the past, but had not been established using RNAi
and RasV12 in combination with Reaper yet, which is one of our goals in this experiment.
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1.4 Hypothesis and Specific Aims
We plan to establish a method to manipulate gene expression in two cell populations.
One population is expected to grow into a glioma tumor while the second is expected to
comprise of cells that express stress – or wound – healing related genes to study effects
on the neighboring glioma tumors. This will allow generation of two genetically distinct
mosaic populations in the developing the Drosophila brain, and allow us to test our
hypothesis that interclonal interactions promote tumor growth. We have devised two
aims for this project:

Aim 1 Generate a positively marked 2-clone interclonal model.
Using knowledge from the preliminary data, we will make additional crosses with Cutlex-A and other stocks such as UAS Gal4 and LexAOP Reaper based system to generate
tumor growth in the Drosophila brains. We will also make crosses of Cut-lexA with
RasV12 that will introduce big tumor growth to Drosophila to try to understand the
behavior of the glia cells surrounding the dead tumor cells. The final goal is to make:
UASGFP LexAOPRFP/ UASPtenRNAi; RasV12/cutlexA; repoGal4/+ larvae. In these the
repoGal4 will drive GFP, and activate Ras and PI3K (through UASPtenRNAi), whereas
Cut-LexA will drive RFP and LexAOP-Reaper.
Aim 2 Test interclonal tumor interactions using apoptotic and cytotoxic stress.
Using antibodies as markers, we will dissect larvae of the type generated in Aim 1 to test
(1) effect on tumor size, and (ii) interclonal tumor interactions. We hope to target those
glia cells that grow as closest in proximity to the tumor growth that will allow us to
further examine and understand behavior of the surrounding cells signals when the tumor
cells die.
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Chapter 2
Materials and Methods
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2.1 Drosophila melanogaster as Model Organism
The cost, availability, and ease of use makes Drosophila melanogaster an ideal organism
of interest for genetic studies. Compare to other organisms such as mice, D. melanogaster
are more cost efficient to maintain and perform experiments on. They have a quick
generation turnover rate; metamorphoses from egg to larvae to pupa to adult within the
span of 12 days. They also have a high fecundity rate that makes it more readily
available. In addition, D. melanogaster has a small number of chromosomes, which
makes it less complicated than organisms with a larger number of chromosomes to
manipulate. D. melanogaster has many basic biological, physiological, and neurological
properties that are conserved from human diseases, with approximately 75% of known
human disease genes have recognizable matches in the fly genome; making them a
powerful tool to understand disease mechanics and develop novel therapeutics (Pandey et
al, 2011).
Fruit flies used in this experiment were obtained from colleagues as well as from
Bloomington, Indiana. They were maintained at 24°C room temperature and placed in
29°C temperature when necessary. Rearing flies at this temperature increase the
generation turnover rate compare to room temperature.
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2.2 Tissues Specific Gene Expression Using Gal4-UAS System and LexA-LexAOP
System
D. melanogaster underwent many crossing schemes in order to create two lines with
various components of Gal4-UAS system and LexA-LexAOP system that later would be
used to combine into one line. The Gal4-UAS system, was used to co-activate the gliomacausing gene using expressions of UAS RasV12 and UAS PteniRNAi with the Repo Gal4
promoter/driver (Figure 2.1). The Repo Gal4 will drive the GFP and activate the RasV12
and PI3K pathway through UAS PteniRNAi, which introduces tumor growth in the brain.
The LexA flies underwent multiple crossing schemes conducive to creating a line with
LexAOP Reaper that would be expressed using the LexA as a driver (Figure 2.2). The
LexA driver created a protein that allowed it to bind to the transcriptional activator of the
LexAOP Reaper. Once bound, the transcriptional activator is activated and thus the
targeted gene is expressed. The targeted gene in this line is Reaper.
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2.1 Diagram from Nature Reviews depicting the mechanism of how Gal 4-UAS system
operates within the genome of an organism.

Gal 4/UAS System

Lex A/ Lex AOP System

Transcriptional Activator

Gal 4

Lex A

Effector

UAS

Lex AOP

2.2 Table illustrating how GAL 4/UAS and Lex A/Lex AOP works as transcriptional
activator and effector.
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2.3 Experimental Design
To generate this model, we will take advantage of techniques that allow us to manipulate
genes under different regulatory mechanisms. For example, using the Gal4-UAS system,
we will co-activate the glioma causing genes. In our system, expression of UASRasV12
and UASPtenRNAi with the repo GAL4 driver results in induction of glioma brain tumors
in the developing larva.
For this experiment, we plan to combine this system with the LexA-LexAOP system,
which also facilitates the misexpression of genes in flies. We have tested Cut-lexA,
Chimno-lexA, and Ey-lexA with AOP-RFP to track which cells in the fly’s brain will be
affected. Secondly, we tested the effect of a stressed inducing gene Reaper in this system
by crossing Cut-LexA to LexAOP Reaper. The preliminary data have shown promising
results of detecting the Red Fluorescent Protein (RFP) biomarker in Reaper cells.
Antibody staining revealed that out of the three LexA lines tested, Cut-lex-A had cells
growing closest in proximity to the glial cells in the brain lobes. From there, Cut-lex-A
was further crossed and amplified to aid in future studies. This mutant line was put
through a specific crossing scheme with the correct phenotypic F1 flies used to continue
in the next crosses.
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2.4 Using Immunohistochemistry as a Tool to Study Protein Expression and
Localization in 3rd instar D. melanogaster larvae
After achieving the desired phenotypes, either stocks or more crosses were made using
flies from the Cut-LexA lines. Once those lines produce offspring with the phenotypes
we seek, 3rd instar larvae were dissected, mounted, and photographed. D. melanogaster
brain lobes are dissected and stained using standard protocols for immunohistochemistry.
Generally, immunohistochemistry assays are used to show protein expression and
localization.
For the dissection process, we prepared a silicon agar plate with Phosphate Buffer Saline
(PBS) that has a pH of 7.4 to dissect 3rd instar larvae on. The PBS provides the sample an
isotonic solution to dissect in and it also prevents the fly from sticking to the silicon plate.
After separating the brain lobes into 100μL of PBS and discarding the rest, the samples
were fixed in 100μL of 8% parafamaldehyde (PFA) for 20 minutes. Then, the samples
were transferred to an eppendorf tube with 1ml of PBST detergent (Triton). The
eppendorf tubes were placed on the nutator for 10 minutes. PBST detergent was then
removed using a vacuum and this washing process was repeated 2 more times. Once the
washing is completed, if using antibodies, the primary bodies were added into the
eppendorf tube and incubated at 4°C overnight. Antibodies were used to identify
molecular markers staining on the brain lobes. The washing process using PBST was
repeated 3 more times the following day. Secondary antibodies were added following the
wash. The primary antibodies expression were detected by secondary antibodies
containing fluorescence tagged, which shows up under the microscope. The eppendorf
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tube were wrapped in foil and placed on the nutator for an additional 2 hours. The
samples were then washed 3 more times before they was mounted.
The mounting occurred on a slide under a stereomicroscope. After the samples were
mounted, Vectashield were placed on top of the samples and topped by a cover slip. The
cover slips were glued in place using nail polish around the perimeter of the slip to seal
the slip in place. Images of the slides were taken at 20X using the electron microscope
(Olympus Fluoview 100). A Z-stack image was generated by manually setting the focus
of the starting and ending points. The Z-stack image generated by the camera took picture
in slices, and then can be stacked/combined into one whole image. The samples were
then taken at 40X. At least five different samples of the same genotype were taken per
magnification.

P a g e | 17

Chapter 3
Results
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3.1 Introduction
Both Gal4-UAS and LexA-LexAOP systems play a crucial part in this experiment by
providing us a means to manipulating the gene expression of the targeted gene. When
both systems work in conjunction, we expect to have a positively marked two-clone
interclonal model in Drosophila illustrated by cellular biomarkers such as GFP and RFP.
Our goal was to generate such a model (UASGFP LexAOPRFP/ UASPtenRNAi;
RasV12/cutlexA; repoGal4/+) to test interclonal tumor interaction using apoptotic and
cytotoxic stress to determine the effect on tumor size and the intercolonal tumor
interactions.

3.2 Results
Preliminary results (Figure 3.1) reveal the perspective LexA line growth in the brain lobe.
We determined that Ey-LexA and Chimno-LexA lines did not have cell growth in the
closest proximity to glial growth compared to Cut-LexA, and thus, Cut-LexA was
selected to be the line we focused our study on. Illustrated in Figure 3.2 is an image of the
Cut-LexA and its cell growth in perspective to glial cell growth.
From there, we generated the following lines shown on List 3.4. Line #9 (Figure 3.3) that
was generated shows successful differentially marked clone-pairs or “twin-spots” using
the Gal4 and LexAOP binary system.
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Figure 3.1 Left: Ey LexA x LexAOP Reaper; Right: Chimno-LexA x Lex AOP Reaper.
Images obtained by: Minh Ho and Kirti Snidgha

Figure 3.2 Cut LexA x LexAOP Reaper. This displays the close proximity of the CutLexA line with the glial cells. The GFP represents the glial cells and the RFP represents
the Cut-LexA cells. Image obtained by: Minh Ho and Kirti Snidgha

Figure 3.3 UAS RFP Lex AOP GFP; Cut-LexA/Cyo; Repo Gal 4/TM6B x Ywhsflip;
Sp/Cyo; LexAOP Reaper/TM6B
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1. Repo Gal4 UAS GFP
2. Pteni; RasV12 x Repo GFP.
3. YwhsFlp; Sp/Cyo; LexAOP Reaper/TM6B
4. YwhsFlp; Cut-lexA/Cyo; TM3/TM6B*
5. YwhsFlp; Cut-lexA/Cyo; Lex AOP Reaper/TM6B*
6. YwhsFlp; Cut-lexA/Cyo; Repo Gal4/TM6B*
7. UAS Pteni; UAS Ras V12/ RasV12; Lex AOP Reaper/TM6B
8. UAS RFP lex AOP GFP; Cut lexA/Cyo; RepoGal4/TM6B.
9. UAS RFP Lex AOP GFP; Cut Lex A/Cyo; Repo Gal 4/TM6B x Ywhsflip; Sp/Cyo;
LexAOP Reaper/TM6B
Table 3.4 Display stocks and crosses we generated over the span of the experiment.
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3.3 Challenges
Generating complex genotypes with an extensive number of steps came with multiple
challenges. Whether it was due to contamination or unexpected results that differ from
our expectations, we had to analyze, troubleshoot, and restart when needed. After
generating and obtaining data for the lines mentioned above, we tried to create the final
targeted line with the genotype of UASGFP LexAOPRFP/ UASPtenRNAi; RasV12/CutLexA; repoGal4/+ larvae. However, we had a contamination in Line #6 and lost Lines #4
and #5 in the process, which forces us to remake those stocks. We successfully remade
Line #6, although that cost us some time. However, when we tried to use Line #6 and
cross it with the balancer YwhsFlp; Sp/Cyo; TM3/TM6B in a three-step process to
regenerate Line #4 – before using Line #4 to recreate Line #5 – we encountered flies that
had inconsistent phenotypes that require us to troubleshoot.
For this cross, we had acquired the correct phenotype for the parental stocks. After
crossing the parental stocks with each other, offspring (F1) with phenotypes of male, red
eyes, curly wings, stubbles, and TM3 were to be collected in order to cross it with
YwhsFlp; Sp/Cyo; TM3/TM6B to yield an F2 (genotype of YwshFlp; Cut- LexA/cyo;
TM3/TM6B) that can be used to replace the lost stock of Line #4 (Table 3.4). However,
the F1 males collected had every phenotype we sought except eye color. We kept seeing
a mixture of red-eyed males and white-eyed males, instead of the consistent red-eyed
males that were targeted. This step was repeated four more times, yet the F1 yield had a
consistent mixture of red and white-eyed males. Thus, we were unable to replace Line #4
and therefore, could not recover Line #5, preventing us from achieving the end goal:
UASGFP LexAOPRFP/ UASPtenRNAi; RasV12/cutlexA; repoGal4/+.
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The generation time for Drosophila is approximately 12 days long, and thus, each time
we repeated this experiment, it took a month to compete, with a total of four month spent
regenerating this stock. We were only able to repeat this experiment four times within the
time span allotted for this thesis.
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Chapter 4
Discussion
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4.1 Significant results
From the preliminary results, the Cut-LexA illustrates that it grows closest in proximity
to the glial cells. We made Repo Gal4 UAS GFP as a control to see the amount of normal
glial cells presented in the Gal4-UAS system. We also made Pteni; RasV12 x Repo GFP to
visualize the amount of glial cells when tumor cells are present in the brain to use for the
control for our second aim. While there were many crosses and stocks made from the
experiment, the genotype that we wanted was not successfully made. However, the twinspots generated using the binary systems of Gal4 and LexAOP was successfully modeled,
although the expression appeared to be weak. Thus, we were able to complete a part of
Aim 1. Because we were unable to obtain that correct genotype, we couldn’t advance on
to Aim 2.
4.2 Expected Outcomes
With more time to possibility generate the desired stock from the first aim that contains
an overexpression of RasV12 and PtenRNAi to stimulate tumor growth in one population,
and stimulate Reaper to cause cell death in another population of the cell, it is expected
that the genotype modeled will allow us to study how the interclonal interaction
influences the growth of tumors. This two-marked population can be quantified in the
brain and we can test this interclonal interaction by controlling the tumor, surrounding
cells, or both in the population. With the binary system, we can see where glioma is in the
human brain and try to drive that expression.
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4.3 Future Research
For the future research, we wish to generate the second aim and examine the interclonal
interaction between tumors and neighboring cells. We also will try a different strategy
and test it from a different LexA line such as using Chimno-LexA and Diachete-LexA.
For this experiment, we targeted every glial cell growth in the brain by choosing CutLexA. However, if we try another strategy and target the glial cells that only grow in the
frontal area – since the expression of glioblastoma grows mainly in the frontal area of the
brain in humans – we can use Chimno-LexA and Dichaete-LexA line instead. The
experimental plan will be the same but we will use a different type of LexA line and
hopefully that will allow us to successfully understand tumor growth interactions better in
Drosophila and thus, can better understand human glioma.
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